Document is current
Any future updates will be listed below
-
Authors
Lalmahomed, T. A. https://orcid.org/0000-0002-9007-5713
Monninkhof, E. M.
van Rijssel, M. J.
van Melick, H. H. E.
Verkooijen, H. M.
de Boer, J. C. J.
van der Voort van Zyp, J. R. N.
- License Information
-
More Information
Article History
Received: 5 February 2025
Accepted: 10 November 2025
First Online: 29 December 2025
Declarations
:
: This study is approved by the medical ethical review board NedMec, Utrecht, The Netherlands, on 19 January 2024 (reference number 23–249). Patients are asked for informed consent to participate in the study, knowing that they will be randomized between the standard and the experimental arm; for the use of data collected within this study for future research, and to be approached by the study team for future studies.
: Participant information materials and the informed consent form are available from the corresponding author upon request.
: HM Verkooijen receives research funding from Elekta, the European Commission, the Dutch Cancer Foundation and the Dutch Research Council. JRN van der Voort van Zyp receives speaker fees from Elekta and Prevents. The other authors do not have any competing interests.
